Aytu Biopharma AYTU
NASDAQ AYTU
$1.79 -0.04 (-2.19%)
At close: Nov 9, 2026 · 4:00 PM EST

Aytu Biopharma (AYTU) Deferred Taxes (2014)

Updated

Aytu Biopharma (AYTU) reported Deferred Taxes of -$23,910 for FY2015 (year ended Jun 30, 2015), compared with -$813,697 in FY2014.

Analysis

Aytu Biopharma (AYTU) Deferred Taxes (2014) Analysis & Trends

  • According to Business Quant data, Deferred Taxes came in at -$813,697 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -665.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -1.79 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -56.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -612.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -120.00 Mn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 202.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -860.00 Mn
10 Aytu Biopharma 22.17 Mn -93.50 Mn 10.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -1.00
Sep 30, 2014 -23,909.00
Jun 30, 2014 -264,538.00
API Access

Aytu Biopharma Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=AYTU&period=max&api_key=YOUR_API_KEY